CVS CVS HEALTH Corp

NYSE cvshealth.com


$ 77.95 $ -1.43 (-1.8 %)    

Friday, 14-Nov-2025 15:55:01 EST
QQQ $ 608.45 $ 0.46 (0.08 %)
DIA $ 471.65 $ -2.94 (-0.62 %)
SPY $ 671.62 $ -0.11 (-0.02 %)
TLT $ 88.93 $ -0.51 (-0.57 %)
GLD $ 375.82 $ -6.91 (-1.8 %)
$ 77.81
$ 79.39
$ 78.05 x 164
$ 78.15 x 283
$ 77.95 - $ 79.60
$ 41.77 - $ 85.15
5,170,917
na
98.77B
$ 0.57
$ 210.61
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-29-2025 09-30-2025 10-Q
2 07-31-2025 06-30-2025 10-Q
3 05-01-2025 03-31-2025 10-Q
4 02-12-2025 12-31-2024 10-K
5 11-06-2024 09-30-2024 10-Q
6 08-07-2024 06-30-2024 10-Q
7 05-01-2024 03-31-2024 10-Q
8 02-07-2024 12-31-2023 10-K
9 11-01-2023 09-30-2023 10-Q
10 08-02-2023 06-30-2023 10-Q
11 05-03-2023 03-31-2023 10-Q
12 02-08-2023 12-31-2022 10-K
13 11-02-2022 09-30-2022 10-Q
14 08-03-2022 06-30-2022 10-Q
15 05-04-2022 03-31-2022 10-Q
16 02-09-2022 12-31-2021 10-K
17 11-03-2021 09-30-2021 10-Q
18 08-04-2021 06-30-2021 10-Q
19 05-04-2021 03-31-2021 10-Q
20 02-16-2021 12-31-2020 10-K
21 11-06-2020 09-30-2020 10-Q
22 08-05-2020 06-30-2020 10-Q
23 05-06-2020 03-31-2020 10-Q
24 02-18-2020 12-31-2019 10-K
25 11-06-2019 09-30-2019 10-Q
26 08-07-2019 06-30-2019 10-Q
27 05-01-2019 03-31-2019 10-Q
28 02-28-2019 12-31-2018 10-K
29 11-06-2018 09-30-2018 10-Q
30 08-08-2018 06-30-2018 10-Q
31 05-02-2018 03-31-2018 10-Q
32 02-14-2018 12-31-2017 10-K
33 11-06-2017 09-30-2017 10-Q
34 08-08-2017 06-30-2017 10-Q
35 05-02-2017 03-31-2017 10-Q
36 02-09-2017 12-31-2016 10-K
37 11-08-2016 09-30-2016 10-Q
38 08-02-2016 06-30-2016 10-Q
39 05-03-2016 03-31-2016 10-Q
40 02-09-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 wells-fargo-maintains-overweight-on-cvs-health-lowers-price-target-to-102

Wells Fargo analyst Stephen Baxter maintains CVS Health (NYSE:CVS) with a Overweight and lowers the price target from $103 t...

 eli-lilly-drops-cvs-healths-drug-benefit-plan-for-employees-ahead-of-2026-switch

Eli Lilly to drop CVS Health's drug benefit plan and move to Rightway in 2026 as Novo Nordisk cuts Wegovy prices in India t...

 eli-lilly-ceo-slams-pbm-rent-taking-says-they-drove-insulin-list-prices-to-275-we-can-disintermediate-them-easily

Eli Lilly CEO Dave Ricks slams PBM "rent taking" for driving $275 insulin price bubble and explains why he's ready ...

 pete-buttigieg-slams-trumps-bad-deal-on-health-insurance-cites-cbo-estimate-of-10-premium-hikes-losing-on-the-economy

Pete Buttigieg says Trump's ATC attack is a distraction from his "bad deal" on health insurance and failure on "...

 insurers-slide-as-congress-postpones-decision-on-health-subsidies-delays-obamacare-subsidy-vote-to-december

Health insurer stocks fell after the Senate ended the shutdown without extending ACA subsidies, delaying the decision to Decemb...

Core News & Articles

https://trumpstruth.org/statuses/33744

 td-cowen-maintains-buy-on-cvs-health-raises-price-target-to-100

TD Cowen analyst Charles Rhyee maintains CVS Health (NYSE:CVS) with a Buy and raises the price target from $99 to $100.

 evercore-isi-group-maintains-outperform-on-cvs-health-raises-price-target-to-95

Evercore ISI Group analyst Elizabeth Anderson maintains CVS Health (NYSE:CVS) with a Outperform and raises the price target ...

 rbc-capital-maintains-outperform-on-cvs-health-raises-price-target-to-93

RBC Capital analyst Ben Hendrix maintains CVS Health (NYSE:CVS) with a Outperform and raises the price target from $81 to $93.

 cantor-fitzgerald-maintains-overweight-on-cvs-health-raises-price-target-to-95

Cantor Fitzgerald analyst Sarah James maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $78...

 truist-securities-reiterates-buy-on-cvs-health-raises-price-target-to-95

Truist Securities analyst David Macdonald reiterates CVS Health (NYSE:CVS) with a Buy and raises the price target from $92 t...

 sp-500-tops-6900-ahead-fed-rate-move-gold-reclaims-4000-whats-moving-markets-wednesday

A powerful surge in AI-related stocks — led by a 9% advance in NVIDIA Corp. (NASDAQ:NVDA) over the past two sessions — propelle...

 cvs-health-delivers-confident-outlook-after-q3-performance-stock-hits-52-week-high

CVS Health topped Q3 estimates with $102.9 billion in revenue and raised its 2025 EPS outlook to up to $6.65 amid strong segmen...

 cvs-health-lowers-fy2025-gaap-eps-guidance-from-384-394-to-034-024-vs-396-est

CVS Health (NYSE:CVS) lowers FY2025 GAAP EPS guidance from $3.84-$3.94 to $(0.34)-$(0.24) vs $3.96 analyst estimate..

 cvs-health-raises-fy2025-adj-eps-guidance-from-630-640-to-655-665-vs-638-est

CVS Health (NYSE:CVS) raises FY2025 Adj EPS guidance from $6.30-$6.40 to $6.55-$6.65 vs $6.38 analyst estimate..

 cvs-health-q3-adj-eps-160-beats-137-estimate-sales-102871b-beat-98849b-estimate

CVS Health (NYSE:CVS) reported quarterly earnings of $1.60 per share which beat the analyst consensus estimate of $1.37 by 16.8...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION